51-OR: The novel mechanisms of tolerance induction contribute to long term survival of heart grafts in MHC class I-mismatched host

2011 ◽  
Vol 72 ◽  
pp. S191
Author(s):  
Yuantao Wang ◽  
Honglan Zhou ◽  
Yu Hu ◽  
Weigang Wang ◽  
Yaowen Fu
1993 ◽  
Vol 56 (5) ◽  
pp. 1166-1170 ◽  
Author(s):  
Janet R. Serie ◽  
Jeanne A. Pringle ◽  
Hanna N. Cooper ◽  
Celest M. Roth ◽  
Orion D. Hegre

2003 ◽  
Vol 77 (18) ◽  
pp. 10060-10070 ◽  
Author(s):  
Martin L. Moore ◽  
Corrie C. Brown ◽  
Katherine R. Spindler

ABSTRACT Infection of adult C57BL/6 (B6) mice with mouse adenovirus type 1 (MAV-1) results in dose-dependent encephalomyelitis. Utilizing immunodeficient mice, we analyzed the roles of T cells, T-cell subsets, and T-cell-related functions in MAV-1-induced encephalomyelitis. T cells, major histocompatibility complex (MHC) class I, and perforin contributed to acute disease signs at 8 days postinfection (p.i.). Acute MAV-1-induced encephalomyelitis was absent in mice lacking T cells and in mice lacking perforin. Mice lacking α/β T cells had higher levels of infectious MAV-1 at 8 days, 21 days, and 12 weeks p.i., and these mice succumbed to MAV-1-induced encephalomyelitis at 9 to 16 weeks p.i. Thus, α/β T cells were required for clearance of MAV-1. MAV-1 was cleared in mice lacking perforin, MHC class I or II, CD4+ T cells, or CD8+ T cells. Our results are consistent with a model in which either CD8+ or CD4+ T cells are sufficient for clearance of MAV-1. Furthermore, perforin contributed to MAV-1 disease but not viral clearance. We have established two critical roles for T cells in MAV-1-induced encephalomyelitis. T cells caused acute immunopathology and were required for long-term host survival of MAV-1 infection.


2021 ◽  
Author(s):  
Qiang Lu ◽  
Hong-Fan Ding ◽  
Yong Wan ◽  
Jia-Wei Yu ◽  
Lu Ren ◽  
...  

Abstract BACKGROUND The removal of bilirubin from serum is the primary method for treating hyperbilirubinemia. However, currently used treatment methods have several limitations.AIMTo introduce a novel method to remove bilirubin from the blood of jaundiced rats.METHODS This novel therapy involved cross-circulation of blood between a rat liver preserved in vitro and a rat with hyperbilirubinemia. The liver was perfused with blood from the model animal, resulting in the clearance of serum bilirubin. Twenty rats with jaundice caused by acute liver failure induced using D-galactosamine were treated. All model animals were randomly divided into two groups based on whether they received the novel therapy. Serum samples were collected before modelling, at the beginning of treatment, and 2 hours after treatment. The levels of serum transaminase and bilirubin were detected and compared between different time points. Histological examination of the liver in vitro was also performed after the treatment. Long-term survival was compared by Kaplan-Meier analysis between rats who did and did not receive the novel treatment.RESULTSIn vitro, the liver could be perfused with the blood from the model animal through the portal vein. The bile produced by the liver after 1 hour of therapy was darker than the bile produced while harvesting. Across different hyperbilirubinemia models, serum total bilirubin level was significantly improved (24.8 ± 1.2 vs. 17.4 ± 1.2 μmol/L, P<0.05), despite a rise serum transaminase levels after treatment (AST: 4612 ± 382 vs. 5144 ± 390 U/L, P>0.05; ALT: 5051 ± 722 vs. 5488 ± 707 U/L, P<0.05). No necrosis was found in the preserved liver tissue after treatment, and the hepatic lobule structure was normal. Hepatocyte necrosis was not found on histological examination. This novel treatment significantly raised the long-term survival rates of jaundiced rats (P <0.05).CONCLUSIONThis novel method could safely and effectively help eliminate bilirubin from the blood of jaundiced rats.


2006 ◽  
Vol 22 (08) ◽  
Author(s):  
Michael Pelzer ◽  
Mikko Larsen ◽  
Yang-Guk Chung ◽  
Teruyasu Ohno ◽  
Patricia Friedrich ◽  
...  

2008 ◽  
Vol 33 (5) ◽  
pp. 484-487 ◽  
Author(s):  
S. Zimmer ◽  
O. Göhlich ◽  
S. Rüttermann ◽  
H. Lang ◽  
W. H-M. Raab ◽  
...  

Clinical Relevance Class I and II CAD-CAM ceramic restorations can be considered durable alternatives to direct and laboratory-fabricated restorations.


2000 ◽  
Vol 111 (1) ◽  
pp. 363-370 ◽  
Author(s):  
Katsuto Takenaka ◽  
Mine Harada ◽  
Tomoaki Fujisaki ◽  
Koji Nagafuji ◽  
Shinichi Mizuno ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A747-A748
Author(s):  
S DRESNER ◽  
A IMMMANUEL ◽  
P LAMB ◽  
S GRIFFIN

Sign in / Sign up

Export Citation Format

Share Document